Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-21

Clinical Trial Update: Low Dose Ketamine for Blunt Thoracic Trauma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating low-dose ketamine for blunt thoracic trauma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: North Memorial Health Care | Conditions: Blunt Injury of Thorax, Multiple Rib Fractures, Involving Three Ribs | Phase 4 | Status: COMPLETED | Results posted: 2024-05-21